Mark Steven Lewis, M.D.

Media Releases

Get to know Oncologist Dr. Mark Steven Lewis, who serves patients in Hollywood, Florida.

Well-versed in the field of oncology, Dr. Lewis works with patients at Oncology Associates of South Florida. He specializes in medical oncology, hematology and internal medicine, performing procedures like bone marrow biopsy and chemotherapy, as well as treating various cancers and malignancies.

Licensed to practice medicine in Florida and New York, he is also affiliated with Memorial Regional Hospital South and Memorial Hospital Pembroke.

In regards to his educational background, Dr. Lewis earned his medical degree from the University of Torino Faculty of Medicine in Italy in 1985. He then went on to complete his residency in internal medicine at North Shore University Hospital in 1988, followed by his fellowship in hematology-oncology with the North Shore – Long Island Jewish Health System in 1991.

A member of the American Society of Clinical Oncology, he is board-certified in medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. They have special training in diagnosing and treating cancer in adults using chemotherapy, hormonal therapy, biological therapy, and targeted therapy.

Throughout his storied career, Dr. Lewis has been the recipient of various accolades, including the Patients’ Choice Award (2014), Compassionate Doctor Recognition (2014), and On-Time Doctor Award (2014).

On a more personal note, he speaks English, Italian, and Spanish.

Recommended Articles

• New Combination Therapy for Hodgkin's Lymphoma Shows Promising Results

  While there are several different types of Hodgkin’s lymphoma, more than 80% of cases of diagnosed lymphoma are non-Hodgkin’s lymphoma. Patients with non-Hodgkin’s lymphoma typically receive radiation therapy, chemotherapy, or combinations of the two. Stem cell or bone marrow transplantations...

• This Drug Significantly Stops Cell Growth in Metastatic Breast Cancer

  HER2-negative metastatic breast cancer is a common yet incurable disease that has spread from the breast to other parts of a person’s body. It’s an aggressive cancer that usually affects the breast plus a patient's bone, lungs, liver and brain. Even when breast cancer spreads into other parts of...

• Is it Possible to Recover from Stage IV Breast Cancer?

  Whether you have just recently been diagnosed with stage IV breast cancer, or you are just now recovering from the shock, you are certainly filled with bewilderment and confusion with all of the information that has been thrown at you in such a short period of time. The moment you first heard those...

• This Woman's Battle Against Cancer Raises Awareness

  Fighting against cancer is a gigantic battle for anyone who faces it, and it can be hard to even think about anything else during. However, some women are such powerful warriors that they not only fight the fight themselves, but also strive to raise awareness.Teri's storyMany women in Teri...

• Leptomeningeal Disease: When Breast Cancer Metastasize to the Brain

  Introduction When breast cancer cells spread to the brain, it is called as brain metastases or secondary breast cancer. It is also known as metastatic breast cancer, advanced breast cancer, secondary or stage four breast cancer, or secondary tumor. When cancer cells reach the brain, it cannot be...

• Is a Mastectomy an Efficient Option to Treat Breast Cancer?

  A mastectomy refers to the surgery performed to remove the breasts, either completely or partially. This was one of the traditional methods in the treatment of breast cancer for a long time. It is also used as a method to reduce the chances of developing breast cancer for women who have a high risk...